Point72 Asset Management, L.P. 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:53 pm Sale | 2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 2,709,292 3.000% | -1,723,310 (-38.88%) | Filing |
| 2024-02-23 4:15 pm Purchase | 2024-02-22 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 4,432,602 5.000% | 435,057 (+10.88%) | Filing |
| 2024-02-14 06:30 am Sale | 2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 3,997,545 4.500% | -87,999 (-2.15%) | Filing |
| 2023-07-20 4:15 pm Purchase | 2023-07-18 | 13G | Caribou Biosciences, Inc. CRBU | Point72 Asset Management, L.P. | 4,085,544 5.100% | 4,085,544 (New Position) | Filing |